• Gio. Nov 21st, 2024

neoantigens

  • Home
  • Bacterial vaccine shows promise as cancer immunotherapy

Bacterial vaccine shows promise as cancer immunotherapy

Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s…

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses…